These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. Yu X; Huang Y; Collin-Osdoby P; Osdoby P J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451 [TBL] [Abstract][Full Text] [Related]
9. The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors. Ohyama Y; Ito J; Kitano VJ; Shimada J; Hakeda Y PLoS One; 2018; 13(1):e0191192. PubMed ID: 29342179 [TBL] [Abstract][Full Text] [Related]
10. Protein phosphatase 2A as a new target for downregulating osteoclastogenesis and alleviating titanium particle-induced bone resorption. Wang L; Guo X; Zhou W; Ding Y; Shi J; Wu X; Liu Y; Xu Y; Yang H; Geng D Acta Biomater; 2018 Jun; 73():488-499. PubMed ID: 29656074 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling. Ping Z; Wang Z; Shi J; Wang L; Guo X; Zhou W; Hu X; Wu X; Liu Y; Zhang W; Yang H; Xu Y; Gu Y; Geng D Acta Biomater; 2017 Oct; 62():362-371. PubMed ID: 28867647 [TBL] [Abstract][Full Text] [Related]
13. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189 [TBL] [Abstract][Full Text] [Related]
14. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha. Dai SM; Nishioka K; Yudoh K Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886 [TBL] [Abstract][Full Text] [Related]
15. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. Michael H; Härkönen PL; Väänänen HK; Hentunen TA J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275 [TBL] [Abstract][Full Text] [Related]
16. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity. Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591 [TBL] [Abstract][Full Text] [Related]
17. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. Shalhoub V; Faust J; Boyle WJ; Dunstan CR; Kelley M; Kaufman S; Scully S; Van G; Lacey DL J Cell Biochem; 1999 Feb; 72(2):251-61. PubMed ID: 10022507 [TBL] [Abstract][Full Text] [Related]
18. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Takahashi N; Udagawa N; Suda T Biochem Biophys Res Commun; 1999 Mar; 256(3):449-55. PubMed ID: 10080918 [TBL] [Abstract][Full Text] [Related]
19. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation. Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801 [TBL] [Abstract][Full Text] [Related]
20. Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL-induced activation of NF-κB and ERK. Ang E; Liu Q; Qi M; Liu HG; Yang X; Chen H; Zheng MH; Xu J J Cell Biochem; 2011 Jan; 112(1):89-97. PubMed ID: 20683903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]